Private equity specialist makes successful exit from clinical trials business

The FutureMeds team
HGL Private Capital has sold its stake in FutureMeds, a leading European independent clinical trials business, to Phoenix Equity Partners, making a successful exit from the business. The West Midlands-headquartered private equity specialist has reported a 10 times money multiple on its initial investment, made in 2021. The HGL Private Capital team say the exit marks an important milestone for FutureMeds, demonstrating its recent growth and innovation in the clinical trials sector. Headquartered in Wroclaw in Poland, FutureMeds h... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
Close